Observing severe dengue cases in critical care in Villavicencio, Colombia.
Characteristics of Patients With Severe Dengue Admitted in Critical Care Units at Villavicencio, Colombia. A Retrospective Observational Trial.
Hospital Departamental de Villavicencio · NCT05938647
This study looks at patients with severe dengue in critical care in Colombia to see how they are treated and what happens to them, aiming to improve care for future cases.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | N/A to 120 Years |
| Sex | All |
| Sponsor | Hospital Departamental de Villavicencio (other) |
| Locations | 2 sites (Villavicencio, Meta and 1 other locations) |
| Trial ID | NCT05938647 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients admitted to critical care units with severe dengue, particularly during epidemic outbreaks. It aims to gather data on the clinical characteristics, treatment approaches, and outcomes of these patients, as current guidelines lack performance data specific to the local context. The study will monitor factors such as organ dysfunction, hemorrhagic events, and capillary leak, which are critical in predicting mortality. By analyzing these cases, the study seeks to improve understanding and management of severe dengue in intensive care settings.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with severe dengue who are admitted to critical care units.
Not a fit: Patients with a diagnosis other than dengue or those who test negative for the virus will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance treatment protocols for severe dengue, potentially reducing mortality rates in affected patients.
How similar studies have performed: While there have been several epidemiological studies on dengue, this specific observational approach in critical care settings is relatively novel and underexplored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients admitted at a critical care unit with a diagnose of dengue either clinical or by a positive serology or molecular diagnostic methods. Exclusion Criteria: * Patients with a post admission diagnosis different than dengue either clinical or by a negative serology.
Where this trial is running
Villavicencio, Meta and 1 other locations
- Clinica Primavera — Villavicencio, Meta, Colombia (RECRUITING)
- Hospital Departamental de Villavicencio — Villavicencio, Meta, Colombia (RECRUITING)
Study contacts
- Principal investigator: Norton Perez-Gutierrez, MD — Cooperative University of Colombia
- Study coordinator: Norton Perez-Gutierrez, MD
- Email: norton.perez@hotmail.com
- Phone: 6086660154
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Severe Dengue